Incyte Reports 2019 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Incyte Reports 2019 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte (INCY) PT Raised to $87 at RBC Capital

July 30, 2019 3:18 PM EDT

RBC Capital analyst Brian Abrahams raised the price target on Incyte (NASDAQ: INCY) to $87.00 (from $85.00) while maintaining a Sector Perform rating.

... More

Incyte (INCY) Tops Q2 EPS by 27c, Raises Guidance

July 30, 2019 7:06 AM EDT

Incyte (NASDAQ: INCY) reported Q2 EPS of $0.75, $0.27 better than the analyst estimate of $0.48. Revenue for the quarter came in at $510 million versus the consensus estimate of $496.4 million.

Guidance:

The... More